Inovio pharmaceuticals revenue
WebSector Industry Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $0.477B: $0.002B: Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. WebAug 9, 2024 · Second Quarter 2024 Financial Results. INOVIO reported total revenue was $784,000 for the three months ended June 30, 2024, compared to $273,000 for the same period in 2024. The increase in ...
Inovio pharmaceuticals revenue
Did you know?
WebMar 1, 2024 · INOVIO's net loss for the quarter and year ended December 31, 2024 was $106.9 million, or $0.50 per basic and diluted share, and $303.7 million, or $1.45 per basic and diluted share, respectively, compared to net loss of $24.3 million, or $0.14 per basic … At INOVIO, we promise to treat your data with respect and will not share your … WebRevenue; Medical: Medical - Biomedical and Genetics: $0.278B: $0.010B: Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the …
WebMar 1, 2024 · Inovio Pharmaceuticals press release (NASDAQ:INO): FY GAAP EPS of -$1.17 misses by $0.06.Revenue of $10.26M (+479.7% Y/Y) misses by $0.29M. Seeking Alpha - Go to Homepage Entering text into the ... WebNov 8, 2024 · Inovio (INO) delivered earnings and revenue surprises of 48.28% and 3,880%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
WebApr 13, 2024 · Inovio Pharmaceuticals GAAP EPS of -$1.17 misses by $0.06, revenue of $10.26M misses by $0.29M SA News Wed, Mar. 01 Earnings history by period FQ3 2024 … WebCompany Description: INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device to produce immune responses …
WebApr 4, 2024 · For the year, revenue was $10.3 million, compared to $1.8 million in 2024, thanks to Inovio's $71 million contract with the U.S. Department of Defense for its …
WebINOVIO Pharmaceuticals, Inc. 6 years SVP and Chief Commercial Officer ... • Grew Synvisc Franchise revenue in excess of 20% per year, grew … suzuki jimny black bison priceWebRevenue for Inovio Pharmaceuticals (INO) Revenue in 2024 (TTM): $10.26 M. According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM) is … barnabus dragon ageWebThe average salary for Inovio employees is $74,048 per year. Visit PayScale to research Inovio salaries, bonuses, reviews, benefits, and more! ... About Inovio Pharmaceuticals. … barnabus careWebSep 8, 2024 · INOVIO Plans to Have 100 Million Doses of COVID-19 Vaccine Candidate INO-4800 Manufactured in 2024 INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that Thermo Fisher Scientific, the world … suzuki jimny black australiaWebOct 20, 2024 · Inovio Pharmaceuticals actually saw its revenue drop by 83% per year over three years. The falling revenue is arguably somewhat reflected in the lacklustre return of 11% per year over three years ... barnabus maximus pty ltdWebMar 1, 2024 · INOVIO's net loss for the quarter and year-ended December 31, 2024 was $54.5 million, or $0.22 per basic and diluted share, and $279.8 million, or $1.17 per basic … barnabus libroWebAug 9, 2024 · Total revenue was $273,000 for the three months ended June 30, 2024, compared to $267,000 for the same period in 2024. Total operating expenses were $83.5 million compared to $33.4 million for the same period in 2024. INOVIO's net loss for the three months ended June 30, 2024 was $82.1 million, or $0.39 per basic and diluted … suzuki jimny black bison price philippines